SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-290292
Filing Date
2014-08-01
Accepted
2014-07-31 21:11:16
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d746883d10q.htm 10-Q 436187
2 EX-31.1 d746883dex311.htm EX-31.1 9125
3 EX-31.2 d746883dex312.htm EX-31.2 9124
4 EX-32.1 d746883dex321.htm EX-32.1 5490
  Complete submission text file 0001193125-14-290292.txt   2969513

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20140630.xml EX-101.INS 324701
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20140630.xsd EX-101.SCH 40049
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20140630_cal.xml EX-101.CAL 53271
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20140630_def.xml EX-101.DEF 92262
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20140630_lab.xml EX-101.LAB 281233
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20140630_pre.xml EX-101.PRE 182184
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 141007828
SIC: 2834 Pharmaceutical Preparations